Literature DB >> 10545515

Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease.

J C Morris1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10545515      PMCID： PMC409830          DOI： 10.1172/JCI8560

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.

Authors:  J C Morris; D W McKeel; M Storandt; E H Rubin; J L Price; E A Grant; M J Ball; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

3.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

Authors:  J L Price; P B Davis; J C Morris; D L White
Journal:  Neurobiol Aging       Date:  1991 Jul-Aug       Impact factor: 4.673

4.  The effects of preclinical dementia on estimates of normal cognitive functioning in aging.

Authors:  M Sliwinski; R B Lipton; H Buschke; W Stewart
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1996-07       Impact factor: 4.077

5.  Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test.

Authors:  A F Jorm
Journal:  Alzheimer Dis Assoc Disord       Date:  1997-09       Impact factor: 2.703

6.  Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation.

Authors:  D B Howieson; L A Holm; J A Kaye; B S Oken; J Howieson
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

7.  Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging.

Authors:  E M Ebly; I M Parhad; D B Hogan; T S Fung
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

8.  If we live long enough, will we all be demented?

Authors:  D A Drachman
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

9.  Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

Authors:  J C Troncoso; L J Martin; G Dal Forno; C H Kawas
Journal:  Neurobiol Aging       Date:  1996 May-Jun       Impact factor: 4.673

10.  Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

Authors:  J C Morris; M Storandt; D W McKeel; E H Rubin; J L Price; E A Grant; L Berg
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910
View more
  8 in total

Review 1.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Authors:  Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2007-02-20       Impact factor: 4.673

2.  A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging.

Authors:  Claudio Costantini; Richard Weindruch; Giuliano Della Valle; Luigi Puglielli
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 3.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

Review 4.  Genome-wide association studies for Alzheimer's disease: bigger is not always better.

Authors:  Valentina Escott-Price; John Hardy
Journal:  Brain Commun       Date:  2022-05-17

5.  Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging.

Authors:  M I Miller; M Hosakere; A R Barker; C E Priebe; N Lee; J T Ratnanather; L Wang; M Gado; J C Morris; J G Csernansky
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

6.  Impact of neuroprotection on incidence of Alzheimer's disease.

Authors:  Raúl de la Fuente-Fernández
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

7.  A Novel Aβ40 Assembly at Physiological Concentration.

Authors:  Bogachan Tahirbegi; Alastair J Magness; Maria Elena Piersimoni; Thomas Knöpfel; Keith R Willison; David R Klug; Liming Ying
Journal:  Sci Rep       Date:  2020-06-11       Impact factor: 4.379

Review 8.  The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.

Authors:  Grant L Iverson; C Dirk Keene; George Perry; Rudolph J Castellani
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.